Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

S Rodenhuis; Marijke Bontenbal; QGCM Hoesel; WM Smit; MA Nooij; EE Voest; E van der Wall; P Hupperets; H van Tinteren; JL Peterse; MJ van de Vijver; EGE de Vries

doi:10.1093/annonc/mdl001

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

S Rodenhuis, Marijke Bontenbal, QGCM Hoesel, WM Smit, MA Nooij, EE Voest, E van der Wall, P Hupperets, H van Tinteren, JL Peterse, MJ van de Vijver, EGE de Vries

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

65 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	588-596
Number of pages	9
Journal	Annals of Oncology
Volume	17
Issue number	4
DOIs	https://doi.org/10.1093/annonc/mdl001
Publication status	Published - 2006

Research programs

EMC MM-03-86-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdl001

http://hdl.handle.net/1765/63090

Cite this

@article{3c15809a8f60407dbfac63b954bf3433,

title = "Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer",

author = "S Rodenhuis and Marijke Bontenbal and QGCM Hoesel and WM Smit and MA Nooij and EE Voest and \{van der Wall\}, E and P Hupperets and \{van Tinteren\}, H and JL Peterse and \{van de Vijver\}, MJ and \{de Vries\}, EGE",

year = "2006",

doi = "10.1093/annonc/mdl001",

language = "Undefined/Unknown",

volume = "17",

pages = "588--596",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "4",

}

TY - JOUR

T1 - Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

AU - Rodenhuis, S

AU - Bontenbal, Marijke

AU - Hoesel, QGCM

AU - Smit, WM

AU - Nooij, MA

AU - Voest, EE

AU - van der Wall, E

AU - Hupperets, P

AU - van Tinteren, H

AU - Peterse, JL

AU - van de Vijver, MJ

AU - de Vries, EGE

PY - 2006

Y1 - 2006

U2 - 10.1093/annonc/mdl001

DO - 10.1093/annonc/mdl001

M3 - Article

C2 - 16446318

SN - 0923-7534

VL - 17

SP - 588

EP - 596

JO - Annals of Oncology

JF - Annals of Oncology

IS - 4

ER -